Cypress Asset Management Inc. TX Increases Position in Xylem Inc. (XYL)
Cypress Asset Management Inc. TX boosted its holdings in shares of Xylem Inc. (NYSE:XYL) by 28.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,020 shares of the industrial products company’s stock after buying an additional 7,238 shares during the period. Cypress Asset Management Inc. TX’s holdings in Xylem were worth $2,068,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Harfst & Associates Inc. boosted its stake in Xylem by 26.1% during the second quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after buying an additional 503 shares in the last quarter. Tower Research Capital LLC TRC acquired a new stake in Xylem during the second quarter worth $168,000. Federated Investors Inc. PA boosted its stake in Xylem by 5.8% during the second quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after buying an additional 181 shares in the last quarter. Ballentine Partners LLC acquired a new stake in Xylem during the third quarter worth $210,000. Finally, Wesbanco Bank Inc. acquired a new stake in Xylem during the third quarter worth $213,000. Hedge funds and other institutional investors own 87.39% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Cypress Asset Management Inc. TX Increases Position in Xylem Inc. (XYL)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/11/20/cypress-asset-management-inc-tx-increases-position-in-xylem-inc-xyl.html.
In other Xylem news, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the completion of the transaction, the director now owns 58,831 shares of the company’s stock, valued at approximately $3,897,553.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $65.81, for a total value of $2,505,386.70. Following the transaction, the insider now directly owns 61,979 shares of the company’s stock, valued at approximately $4,078,837.99. The disclosure for this sale can be found here. Insiders sold a total of 83,270 shares of company stock valued at $5,501,312 over the last quarter. 0.75% of the stock is owned by insiders.
Several equities research analysts have recently commented on XYL shares. Royal Bank Of Canada restated an “outperform” rating and issued a $71.00 target price (up previously from $64.00) on shares of Xylem in a research note on Wednesday, October 4th. Canaccord Genuity restated a “hold” rating and issued a $50.00 target price on shares of Xylem in a research note on Friday, July 28th. Stifel Nicolaus restated a “hold” rating and issued a $63.00 target price on shares of Xylem in a research note on Friday, October 13th. Zacks Investment Research upgraded shares of Xylem from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research note on Thursday, October 5th. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating on shares of Xylem in a research note on Tuesday, October 31st. Six research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Xylem currently has an average rating of “Buy” and a consensus price target of $65.17.
Shares of Xylem Inc. (NYSE XYL) traded down $0.06 during mid-day trading on Monday, hitting $66.42. The stock had a trading volume of 561,500 shares, compared to its average volume of 1,230,674. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.88. The company has a market cap of $11,929.03, a PE ratio of 29.00, a PEG ratio of 1.85 and a beta of 1.16. Xylem Inc. has a one year low of $46.67 and a one year high of $67.64.
Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.64 by $0.01. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same period in the previous year, the firm earned $0.54 EPS. Xylem’s quarterly revenue was up 33.2% compared to the same quarter last year. analysts anticipate that Xylem Inc. will post 2.39 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Thursday, November 2nd will be given a $0.18 dividend. The ex-dividend date of this dividend is Wednesday, November 1st. This represents a $0.72 annualized dividend and a dividend yield of 1.08%. Xylem’s dividend payout ratio is presently 41.86%.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.